Advisor Group Holdings, Inc. Allovir, Inc. Transaction History
Advisor Group Holdings, Inc.
- $44.4 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Allovir, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,700 shares of ALVR stock, worth $36,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,700Holding current value
$36,297% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding ALVR
# of Institutions
4Shares Held
730KCall Options Held
0Put Options Held
0About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $913M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...